Table 1.
Type 1 | Type 2 | Type 3 | Type 4 | Type 5 (Lynch syndrome) | |
MSI status | MSI-H | MSS/MSI-L | MSS/MSI-L | MSS/MSI-L | MSI-H |
CIMP | + | + | - | - | - |
Mutations | |||||
BRAF | mutant | mutant | wild-type | wild-type | wild-type |
KRAS | wild-type | wild-type | mutant | wild-type | wild-type |
5-year survival | |||||
n | 100 | 55 | 353 | 631 | 50 |
Overall | 80.5% | 46.2% | 67.8% | 78.0% | 84.1% |
Disease-specific | 89.5% | 49.2% | 72.4% | 82.5% | 93.1% |